H2020 Call – New concepts in patient stratification

Topic identifier: SC1-PM-02-2017 Types of action: RIA Research and Innovation action Deadline: April 11th 2017 Proposals should deliver novel concepts for disease-mechanism based patient stratification to address the needs for stratified or personalised therapeutic interventions. The proposals should integrate multidimensional and longitudinal data and harness the power of -omics, including…

Continue reading

H2020 Call – New therapies for rare diseases

Topic identifier: SC1-PM-08-2017 Types of action: RIA Research and Innovation action Deadline: April 11th 2017 Support will be provided to clinical trials on substances where orphan designation has been given by the European Commission, where the proposed clinical trial design takes into account recommendations from protocol assistance given by the…

Continue reading

EMBL–Wellcome Genome Campus Conference: Proteomics

Through the tremendous advances in the technology of mass spectrometry-based proteomics and its applications, the research has expanded to most areas of biology that deal with proteins. This conference will focus on the application of proteomics to cell biology and unraveling disease mechanisms by addressing conceptually novel ways to study…

Continue reading